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EphA4 signaling regulates phospholipase Cgamma1 activation,
cofilin membrane association, and dendritic spine morphology
Abstract
Specialized postsynaptic structures known as dendritic spines are the primary sites of glutamatergic
innervation at synapses of the CNS. Previous studies have shown that spines rapidly remodel their actin
cytoskeleton to modify their shape and this has been associated with changes in synaptic physiology.
However, the receptors and signaling intermediates that restructure the actin network in spines are only
beginning to be identified. We reported previously that the EphA4 receptor tyrosine kinase regulates
spine morphology. However, the signaling pathways downstream of EphA4 that induce spine retraction
on ephrin ligand binding remain poorly understood. Here, we demonstrate that ephrin stimulation of
EphA4 leads to the recruitment and activation of phospholipase Cgamma1 (PLCgamma1) in
heterologous cells and in hippocampal slices. This interaction occurs through an Src homology 2
domain of PLCgamma1 and requires the EphA4 juxtamembrane tyrosines. In the brain, PLCgamma1 is
found in multiple compartments of synaptosomes and is readily found in postsynaptic density fractions.
Consistent with this, PLC activity is required for the maintenance of spine morphology and
ephrin-induced spine retraction. Remarkably, EphA4 and PLC activity modulate the association of the
actin depolymerizing/severing factor cofilin with the plasma membrane. Because cofilin has been
implicated previously in the structural plasticity of spines, this signaling may enable cofilin to
depolymerize actin filaments and restructure spines at sites of ephrin-EphA4 contact.
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Specialized postsynaptic structures known as dendritic spines are the primary sites of glutamatergic innervation at synapses of the CNS.
Previous studies have shown that spines rapidly remodel their actin cytoskeleton tomodify their shape and this has been associatedwith
changes in synaptic physiology. However, the receptors and signaling intermediates that restructure the actin network in spines are only
beginning to be identified. We reported previously that the EphA4 receptor tyrosine kinase regulates spine morphology. However, the
signaling pathways downstream of EphA4 that induce spine retraction on ephrin ligand binding remain poorly understood. Here, we
demonstrate that ephrin stimulation of EphA4 leads to the recruitment and activation of phospholipase C1 (PLC1) in heterologous
cells and in hippocampal slices. This interaction occurs through an Src homology 2 domain of PLC1 and requires the EphA4 juxtamem-
brane tyrosines. In the brain, PLC1 is found in multiple compartments of synaptosomes and is readily found in postsynaptic density
fractions. Consistent with this, PLC activity is required for the maintenance of spine morphology and ephrin-induced spine retraction.
Remarkably, EphA4 and PLC activity modulate the association of the actin depolymerizing/severing factor cofilin with the plasma
membrane. Because cofilin has been implicated previously in the structural plasticity of spines, this signaling may enable cofilin to
depolymerize actin filaments and restructure spines at sites of ephrin–EphA4 contact.
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Introduction
Dendritic spines are specialized protrusions from the dendritic
shaft where excitatory synapses are formed in the brain. The ste-
reotypic spine has an enlarged head that is connected to the den-
dritic shaft by a constricted neck. This morphology creates a bio-
chemical compartment that accommodates the postsynaptic
density (PSD), a dense region of ion channels and receptors that
are complexed with scaffolding and other signaling proteins
(Kim and Sheng, 2004). Remarkably, spines change their mor-
phology within minutes (Dailey and Smith, 1996; Fischer et al.,
1998; Dunaevsky et al., 1999) and this may adjust the physiology
of synapses during processes such as learning and memory for-
mation (Segal, 2005). Previous studies indicate that this struc-
tural plasticity relies on the dynamics of actin filaments, which
are concentrated in spines and serve as their primary structural
scaffold (Matus, 2000).
Among molecules that may control actin rearrangements in
spines are proteins of the cofilin/actin depolymerization factor
(ADF) family (Bamburg, 1999; Racz andWeinberg, 2006). Cofi-
lin/ADF proteins bind, depolymerize, and sever actin filaments
(Bamburg, 1999). Cofilin activity is negatively regulated by ki-
nases [Lin-11, Isl-1, Mec-3 (LIM) kinase 1/2 and testis-specific
(Tes) kinase] (Arber et al., 1998) and positively regulated by
phosphatases (Slingshot and chronophin) through phosphocy-
cling on a serine residue (Huang et al., 2006). Cofilin is also
modulated by phosphoinositides, especially phosphatidylinositol
4,5-bisphosphate (PIP2). Cofilin has multiple binding sites for
PIP2 (Yonezawa et al., 1990, 1991b) and cofilin–PIP2 interactions
tether cofilin to the cell membrane (Nagaoka et al., 1996; DesMa-
rais et al., 2005) and modulate cofilin activity (Nagaoka et al.,
1995). The cofilin–PIP2 interaction also inhibits the enzyme
phospholipase C1 (PLC1) from cleaving PIP2 when PLC1 is
not tyrosine phosphorylated (Yonezawa et al., 1991b). PLC1 is
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activated by receptor tyrosine kinases (RTKs), enabling it to hy-
drolyze PIP2 into IP3 and DAG (Rebecchi and Pentyala, 2000).
Cofilin and PLC1 are important regulators of cell morphology
and implicated in synaptic plasticity (Reyes-Harde and Stanton,
1998; Micheva et al., 2001; Meng et al., 2002; Zhou et al., 2004).
However, the receptors that control these proteins at synapses
remain to be fully described.
Several classes of RTKs may regulate PLC1 and cofilin, in-
cluding those of the Eph family. Eph receptors are divided into
EphA and EphB subtypes (Kullander and Klein, 2002). In gen-
eral, EphA receptors bind glycosylphosphatidylinositol-
anchored ephrin-As, whereas EphB receptors respond to trans-
membrane ephrin-Bs. Eph receptors are important for spine
morphogenesis and maintenance in vitro and in vivo (Ethell and
Pasquale, 2005). Several signaling mechanisms have been eluci-
dated for EphB receptors in spines, however, those downstream
of EphA receptors remain to be described.
Here, we identify an EphA4 signaling pathway that regulates
spine morphology. We show that EphA4 triggers PLC1 activa-
tion through an Src homology 2 (SH2) domain interaction with
the juxtamembrane tyrosines of EphA4. PLC signaling is neces-
sary for maintaining spine morphology and for ephrin-induced
spine retraction. Remarkably, EphA4 and PLC signaling alter the
membrane association of cofilin. We propose that EphA4 pro-
motes PLC1 signaling to allow cofilin translocation away from
the cell membrane, enabling it to depolymerize actin filaments in
spines at sites of ephrin-A/EphA4 contact.
Materials andMethods
DNA constructs. Full-lengthmouse PLC1 was cloned from an expressed
sequence tag vector (IMAGE clone 6854923; Open Biosystems, Hunts-
ville, AL) through PCR and ligated in-frame into pcDNA3 with a V5
epitope tag (Invitrogen, Carlsbad, CA). The lipase-inactive PLC1 mu-
tant (H335Q) (Huang et al., 1995; Ronnstrand et al., 1999; Rong et al.,
2003) and EphA4 juxtamembrane tyrosine mutants (Y596E and Y602E)
were created using standard PCR-based mutagenesis (Zisch et al., 2000;
Cowan et al., 2005). The EphA4 kinase-dead construct has been de-
scribed previously (Murai et al., 2003a). The N- and C-terminal SH2
domains of PLC1 were cloned into pGEX-4T1 (Promega, San Luis
Obispo, CA) and used for glutathione S-transferase (GST) fusion protein
production using standard procedures.
For RNAi constructs, a short hairpin sequence directed against mouse
PLC1 (Patterson et al., 2002)was cloned into pSUPER (OligoEngine, Seat-
tle, WA) containing the H1 promoter for driving the expression of a short-
hairpin RNA and a phosphoglycerate kinase promoter for expressing green
fluorescent protein (GFP). To more thoroughly delineate dendritic spines,
the GFP sequence was replaced with membrane-targeted farnesylated en-
hanced GFP (EGFPf; BD Biosciences, San Jose, CA). To generate RNAi
plasmids, two complementary oligos containing the PLC1 shRNA were
annealed (sequences 5GATCCCCAAACAACCGGCTCTTCGTCT-
TCAAGAGAGACGAAGAGCCGGTTGTTTTTTTTA3 and 5AGCTT-
AAAAAAAACAACCGGCTCTTCGTCTCTCTTGAAGACGAAGAGCCGG-
TTGTTTGGG3) and cloned into the BglII and HindIII sites of pSUPER. A
shRNA vector containing a scrambled sequence of the PLC1 shRNA se-
quence, which did not show homology to themouse genome, was cloned in a
similar manner and used in control experiments (sequences
5GATCCCCTAGACCTATATCCCTGCGCTTCAAGAGAGCGCAGGGAT-
ATAGGTCTATTTTTA3 and 5AGCTTAAAAATAGACCTATATCCCTG-
CGCTCTCTTGAAGCGCAGGGATATAGGTCTAGGG3).
Antibodies and recombinant proteins. The following antibodies were
used in this study:mouse PLC1 (mousemonoclonal;Millipore, Upstate
Division, Billerica, MA); PLC1 (rabbit polyclonal; Cell Signaling Tech-
nologies, Danvers, MA); pY783 PLC1 (Cell Signaling Technologies);
pY771 PLC1 (Cell Signaling Technologies); pS1248 PLC1 (Millipore);
EphA4 (Soans et al., 1994; Murai et al., 2003a); pY20 (BD Biosciences);
synaptosomal-associated protein 25 (SNAP25) (a generous gift fromDr.
P. McPherson, Montreal Neurological Institute), synaptophysin (Sigma,
St. Louis, MO); PSD95 (BD Biosciences); NR1 (BD Biosciences); cofilin
(Cell Signaling Technologies; Cytoskeleton, Denver, CO); V5 (Sigma);
transferrin receptor (Invitrogen); GAPDH (glyceraldehyde-3-phosphate
dehydrogenase; Abcam, Cambridge, MA); anti-rabbit and mouse HRP
(GEHealthcare, Fairfield, CT); and control mouse IgGs (Jackson Immu-
nochemicals, West Grove, PA). The following recombinant proteins
were used: human IgG Fc (Jackson Immunochemicals), EphA4 kinase
domain (Cell Signaling Technologies), and ephrin-A3 and -A5 Fc (R&D
Systems, Minneapolis, MN).
Immunoprecipitation and Western blot analysis. For COS7 cell experi-
ments, EphA4 and juxtamembrane mutants were transfected with Lipo-
fectamine 2000 (Invitrogen) and stimulated 24 h later for 45 min with
dimeric control Fc, ephrin-A3 Fc, or ephrin-A5 Fc. Cells were lysed in
modified radioimmunoprecipitation assay (RIPA) buffer (1% Triton
X-100; 1% sodium deoxycholate; 0.1% SDS; 20mMTris; 150mMNaCl; 1
mM EDTA) containing protease inhibitors and orthovanadate. Lysates
were subjected to immunoprecipitation using 2g ofmouse anti-PLC1
or mouse IgG control and coupled to protein-G Sepharose (GE Health-
care). The degree of phosphorylation was determined using an antibody
against pY783 and a protein-A HRP secondary antibody. The amount of
immunoprecipitated protein was detected by stripping and reprobing
membraneswith rabbit anti-PLC1. Alternatively, transfected cell lysates
were directly probed with anti-pY783, -pY771, or -pS1248 and stripped
and reprobed for PLC1. For densitometry, the amount of phosphory-
lation was quantified using ImageJ and was normalized against the total
PLC1 levels. Data was collected over three independent experiments.
For biochemistry involving hippocampal tissue, slices (300 m thick)
were prepared as described previously (Murai et al., 2003a) and kept in
vitro for 2–5 min before stimulation with Fc fusion proteins (9.5 g/
ml). After stimulation for 45 min, slices were lysed in RIPA buffer. Ly-
sates were immunoprecipitated with either anti-EphA4 or anti-PLC1
antibodies coupled to protein-A or protein-G Sepharose, respectively.
Phosphorylation of EphA4 was detected using an anti-phosphotyrosine
antibody (PY20) coupled to HRP. PLC1 phosphorylation was detected
with an anti-pY783 and protein-A HRP. Blots were stripped and re-
probed by immunoblotting with anti-EphA4 or rabbit anti-PLC1 anti-
bodies and anti-rabbit HRP to confirm that equal amounts of protein
were immunoprecipitated from each condition.
The following procedure was used to coimmunoprecipitate EphA4
and PLC1 frommouse hippocampus. Hippocampi were dissected from
the mouse brain at postnatal day 21 and homogenized in Triton lysis
buffer (20 mM Tris pH 7.4, 137 mM NaCl, 25 mM -glycerophosphate, 2
mM EDTA, 1% Triton X-100, 10% glycerol, supplemented with protease
inhibitors and sodiumorthovanadate) using aDounce homogenizer and
lysed on ice for 15min. Lysates were centrifuged at 13,000 rpm for 10min
at 4°C to pellet cell debris. Lysates were precleared for 1 h with protein-G
Sepharose, then subjected to immunoprecipitation using 5 g of mouse
IgG control or mouse anti-PLC1 coupled to protein-G Sepharose for
5 h at 4°C. Immune complexes were washed three times with lysis buffer,
boiled in 40l of 3 SDS sample buffer and resolved by SDS-PAGE. The
association of EphA4 and PLC1was detected by immunoblottingwith a
rabbit anti-EphA4 antibody.
GST pull-down assays.GST fusion proteins were prepared as described
by Zisch et al. (1998). GST fusion proteins (GST, N-terminal SH2
PLC1, or C-terminal SH2 PLC1) coupled to agarose beads were incu-
bated with transfected COS7 cell lysates [EphA4, EphA4 Y596E, or
EphA4 Y602E solubilized in 1% Brij97 (Sigma) in PBS with protease
inhibitors and orthovanadate] overnight at 4°C. The beads were subse-
quently washed with 1% Brij97/PBS (with protease inhibitors and or-
thovanadate), diluted with sample buffer, and boiled for 5 min. Super-
natants were subjected to SDS-PAGE and blotted using anti-EphA4
antibodies and anti-rabbit HRP as described previously.
In vitro kinase assay. For in vitro kinase assays, endogenous PLC1
from COS7 cells was immunoprecipitated as described previously.
PLC1 immunoprecipitates were resuspended in kinase buffer contain-
ing the following (inmM): 25 HEPES, pH 7.4, 25 -glycerophosphate, 25
MgCl2, 0.1 Na3VO4, 0.5 DTT, and 1 ATP. In conditions that included the
activated kinase, 0.5 g of recombinant EphA4 kinase domain was used.
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The reaction mixture was incubated at 30°C for 30 min with gentle agi-
tation every 10min. The reactionwas stopped by adding 25l of 3 SDS
sample buffer and boiled for 5 min. Phosphorylation of PLC1 at Y783
was detected by Western blot analysis using pY783 and protein A-HRP.
The total amount of PLC1 immunoprecipitated was determined by
stripping and reprobing membranes with rabbit anti-PLC1. Data were
collected from three independent experiments and quantified as de-
scribed previously.
Synaptosome preparations. Synaptic proteins were purified as de-
scribed in the supplemental information (available at www.jneurosci.org
as supplemental material).
Cell-membrane preparations. Cell membrane fractionation experi-
ments were performed as described previously (Cote et al., 2005). Briefly,
cells were collected in PBS, centrifuged at 800 g for 5 min, and then
resuspended in 300l of buffer A (20mMTris-HCl pH7.5, 150mMNaCl,
5 mM NaF, 1 mM Na3VO4, 1 g/ml protease inhibitors). The cells were
then subjected to a single freeze/thaw cycle in liquid nitrogen and a 37°C
water bath and the membranes were pelleted using centrifugation at
16,000 g for 10 min. The pellet was then washed with 500 l of buffer A
and extracted with buffer B (buffer A plus 1% Triton X-100). Equal
amounts of proteins were resolved by SDS-PAGE and the levels of
membrane-associated cofilin analyzed by immunoblotting with cofilin
antibodies. Equal loading between samples was confirmed by blotting for
the transferrin receptor. For PLC inhibitor experiments, COS7 cells were
seeded at a density of 1 106 cells/ml and the next day were treated with
either the PLC inhibitor 1-[6[[(17)-3-methoxyestra-1,3,5(10)-trien-
17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122; EMD Biosciences,
La Jolla, CA) or control compound 1-[6-([17-3-methoxyestra-
1,3,5(10)-trien-17-yl]amino)hexyl]-2,5-pyrrolidine-dione (U73343;
EMD Biosciences) at a final concentration of 10 M for 3 h before col-
lecting the cells. For ephrin-stimulation experiments, cells were seeded at
a density of 1 105 cells/ml and the next day transfected with the cDNA
for EphA4 using Lipofectamine 2000 (Invitrogen). Twenty-four hours
after the transfection, the cells were treated with 8 g/ml recombinant
control Fc or ephrinA5-Fc fusion proteins for 40 min at 37°C. Mem-
branes were then fractionated as described above. For densitometry, the
amount of cofilin in each condition was quantified using ImageJ and
normalized against the amount of transferrin receptor. Data was col-
lected over three independent experiments.
For membrane fractionation in hippocampal slices after ephrin stim-
ulation, 300m slices were made from postnatal day 10mice and placed
into stimulation media containing Fc or ephrin-A5 Fc proteins (9.5 g/
ml). After 45 min of stimulation, slices were coarsely homogenized, and
then subjected to a single freeze/thaw cycle followed by the procedure
described above. Data were collected from three independent experi-
ments and quantified as described above.
Immunofluorescence in heterologous cells. For immunofluorescence
studies in heterologous cells, COS7 cells were plated onto chambered
slides (Nunc, Roskilde, Denmark) and transfected as described previ-
ously. Cells were fixed with 4% paraformaldehyde/0.1 M phosphate
buffer for 30 min, rinsed with TBS, and incubated for 1 h in blocking
solution (5% goat serum/0.1% Triton X-100 in TBS). Cells were then
incubated overnight (at 4°C) with anti-pY783 in blocking solution. The
next day, the cells were washed with 0.1% Triton X-100/TBS and incu-
bated with a goat anti-rabbit Alexa 568 secondary antibody (Invitrogen)
for 1 h at room temperature. After washing cells with 0.1%TritonX-100/
TBS, cells were coverslipped for microscopy.
Semliki Forest virus plasmid construction and virus preparation. For
expressing PLC1 constructs and fluorescent proteins in hippocampal
slices, Semliki Forest virus (SFV) constructs were created (Ehrengruber
et al., 1999). PLC1 and membrane-targeted EGFPf (Clontech, Cam-
bridge, UK) genes were each cloned 3 to a viral subgenomic promoter in
modified SFV vectors (Lundstrom et al., 2003). Viral particles were pro-
duced as described previously (Haber et al., 2006). SFV particles were
injected into hippocampal slices with a Picospritzer (General Valve, Fair-
field, NJ).
Hippocampal slice preparation. Organotypic hippocampal slices were
prepared as described previously (Murai et al., 2003a). Briefly, 300 m
slices from postnatal day 6 (P6)–P7 mouse pups were made using a
McIllwain tissue chopper (Stoelting, Kiel, WI) and transferred onto
semiporous tissue culture inserts (0.4 m pore size; Millipore) contain-
ing media (50% Minimum Essential Medium/25% Horse Serum/25%
HBSS/6.5 mg/ml D-glucose/0.5% penicillin/streptomycin, pH 7.2).
Media was replaced every 2 d and slices were cultured for 1 week before
viral gene delivery. Sixteen to 20 h postinfection, slices were fixed and
mounted for confocal imaging.
For imaging hippocampal slices after stimulation, 300 m slices were
made from mice 3 months of age and placed into stimulation media
containing dimeric Fc or ephrin-A5 Fc and U73122 (PLC-inhibitor) or
U73343 for 45 min. The slices were then fixed with 4% paraformalde-
hyde/0.1 M phosphate buffer for 30 min. CA1 pyramidal cells were la-
beled using diolistics. Briefly, 1.3 m tungsten particles (Bio-Rad, Her-
cules, CA) carrying the lipophilic dye DiI (Invitrogen) were coated onto
the inner portion of plastic tubing, cut into cartridges, loaded into a
Helios Gene Gun (Bio-Rad), and propelled into hippocampal slices at
120 psi using helium gas. The DiI was allowed to transport for 16 h in
fixative before imaging by confocal microscopy.
For RNAi experiments, shRNA plasmids (see above, DNA constructs)
were delivered using biolistic gene transfer with a Helios Gene Gun (Bio-
Rad). Briefly, PLC1 shRNA and control shRNA plasmids were precip-
itated onto 1.6 m gold microcarriers and deposited on the inner lining
of Tefzel tubing (Bio-Rad) to generate bullets. Hippocampal slices were
prepared as described above from postnatal day 5 mice and cultured for
9–10 d before propelling gold microcarriers onto hippocampal slices at
100 psi using helium gas. To improve the efficiency of CA1 pyramidal cell
transfection, a 3.0 m membrane filter (Millipore) was placed between
the gene gun nozzle and the hippocampal slices. The shRNA constructs
were allowed to express for 72 h before fixation and imaging by confocal
microscopy.
Confocal imaging. Confocal imaging was performed with a Yokogawa
spinning disk confocal system (Perkin-Elmer,Wellesley,MA) connected
to a Nikon (Tokyo, Japan) Eclipse TE2000. Z-stacks were collected using
MetaMorph imaging software (Molecular Devices, Palo Alto, CA).
Image analysis. For analysis of dendritic spine morphology, images of
dendrites were taken for each condition [control, PLC1 wild-type (wt),
or PLC1 LIM, or PLC1 shRNA or control shRNA] from three inde-
pendent experiments. Each image contained aZ-stackmaximumprojec-
tion of a primary apical dendrite from a CA1 pyramidal cell taken100
m from the cell body (control, 16 dendritic segments with 568 spines
total; PLC1wt, 26 dendritic segmentswith 886 spines total; PLC1 LIM,
22 dendritic segments with 603 spines total). For RNAi experiments, 33
dendritic segments (with 889 spines) were used in the control shRNA
condition and 41 dendritic segments (with 918 spines) in the PLC1
shRNA condition. All images were normalized for EGFPf signal intensity
and thresholded in Photoshop (Adobe Systems, Seattle,WA). Geometric
measurements of spine parameters (length, head width, area, and den-
sity) were acquired using the Reconstruct computer program (http://
synapses.bu.edu/tools/index.htm). Spines were defined as any protru-
sion from the dendritic shaft that is not a dendrite branch. The dividing
line of the spine head and neck was determined subjectively using the
contours of the dendritic spine head. For spines without clearly defined
head portions (i.e., stubby or elongated spines), the spine head area was
considered equal to the total spine area and spine head width equal to the
neck width. For each dendritic segment, the spine parameters were com-
bined to generate an average value that was then used for comparisons.
All quantifications were performed by an investigator blind to the exper-
imental conditions. Using a computer to sort spines according to the
measured parameters, spines were classified into four types (i.e., “mush-
room,” “stubby,” “elongated,” or “other”). Themushroom category cor-
responds to spines that have enlarged head regions with a constricted
neck. Stubby spines lack neck regions. The elongated category includes
filopodia-like spines and long spines with small, but well formed head
regions. The other category includes spines with abnormal dimensions,
such as those with large heads and highly branched spines that do not fit
into the three other categories. Differences between samples were per-
formed using a t test or ANOVAwith a Student–Newman–Keuls post hoc
comparison.
For stimulation experiments, images of dendrites were acquired sim-
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ilar to as described above over three indepen-
dent experiments. Thirty-five dendritic seg-
ments (with 752 spines) were used for the Fc
plus U73343 condition, 33 segments (with 752
spines) were used for the Fc plus U73122 con-
dition, 33 segments (with 686 spines) were used
for the ephrin-A plusU73343 condition, and 31
segments (with 704 spines) were used for the
ephrin-A plus U73122 condition. Quantifica-
tions were performed by an investigator blind
to the experimental conditions and differences
between samples were performed using a Kol-
mogorov–Smirnov test or ANOVA with a Stu-
dent–Newman–Keuls post hoc comparison.
Results
EphA4 activates PLC1 in heterologous
cells and hippocampal slices
Wereported previously that EphA4 activa-
tion with ephrin-A ligands induces den-
dritic spine retraction (Murai et al.,
2003a). However, the downstream signal-
ing cascades of this receptor remain to be
fully described. Using GST pull-down as-
says from hippocampal lysates, we initially
found that EphA4 bound well to an SH2
domain of PLC1, a protein known to be
important for phosphoinositide metabo-
lism, cell morphology, and synaptic func-
tion (Rebecchi and Pentyala, 2000). To
follow up on this observation, we trans-
fected EphA4 into COS7 cells (which have
little endogenous EphA4) while over-
expressing PLC1 (Fig. 1A). EphA4
caused an increase in the phosphorylation of tyrosine 783 of
PLC1, which is critical for PLC1 activity and is an indicator of
its level of activation (Kim et al., 1991; Poulin et al., 2005). This
phosphorylation event, however, was not detected after transfec-
tion of a kinase-dead form of EphA4, suggesting that kinase-
dependent signaling is required for PLC1 activation down-
stream of EphA4.
We were next interested in determining whether stimulation
of EphA4 transfected COS7 cells with recombinant ephrin-A (vs
control Fc) proteins would lead to an elevation in the phosphor-
ylation of endogenous PLC1. In these experiments, we used
endogenous PLC1 because we found that there is high basal
level of PLC1 in COS7 cells. As shown in Figure 1B, ephrin-A
stimulation caused a significant activation of PLC1 as indicated
by its phosphorylation on tyrosine 783. This effect was observed
with both recombinant ephrin-A3 Fc and ephrin-A5 Fc fusion
proteins, but not control Fc (Fc vs ephrin-A3 Fc, p 0.05; Fc vs
ephrin-A5 Fc, p  0.01, ANOVA). We further determined the
specificity of this effect using lysates fromEphA4-transfected cells
stimulated with Fc or ephrin-A5 Fc and found that ephrin treat-
ment caused a significant increase in PLC1 activation (pY783,
260% of control Fc stimulation; p  0.016, two-tail t test) (Fig.
1C). Phosphorylation on tyrosine 771, a residue whose phos-
phorylation is not correlated with PLC1 activity (Kim et al.,
1991), or serine 1248, which is potentially an inhibitory phos-
phorylation site for protein kinases C and A (Park et al., 1992)
were not significantly changed (pY771, p  0.78, two-tail t test,
pS1248; p 0.091, two-tail t test) (Kim et al., 1990, 1991). Con-
sistent with these biochemical studies, we detected an increase in
pY783 labeling of EphA4 transfected COS7 cells stimulated with
ephrin-A Fc using immunofluorescence microscopy (Fig. 1D).
Increased labeling was especially apparent as clusters on the cell
body and processes of stimulated cells. These combined results
show that EphA4 stimulation with ephrin ligands induces PLC1
activation by specifically enhancing its phosphorylation on ty-
rosine 783.
To determine whether ephrin stimulation could activate
PLC1 signaling in the mouse hippocampus, we stimulated hip-
pocampal slices with ephrin-A Fc and monitored the phosphor-
ylation of EphA4 and PLC1. Similar to the experiments using
COS7 cells, we found that ephrin-A Fc treatment caused an in-
crease in phosphorylation of PLC1 on tyrosine 783 (Fig. 2A). To
examine the time course for this activation, we stimulated slices
for varying time periods and found that PLC1 activation was
significantly increased after 45 min of ephrin stimulation (Fig.
2B,C). These results demonstrate that ephrin-A stimulation can
activate endogenous EphA4 andPLC1 signaling in slices derived
from the hippocampus. However, based on these results, we can-
not conclude if PLC1 is activated earlier (i.e., between 15 and 45
min) after the onset of ephrin stimulation. Furthermore, we can-
not exclude the possibility that EphA4 activates PLC1 through
an intermediary protein or that other proteins are activated in
parallel (i.e., a counteracting phosphatase) that cause the delayed
kinetics of PLC1 activation.
EphA4 binds the C-terminal SH2 domain of PLC1 through
juxtamembrane tyrosines
PLC1 is a multidomain signaling protein that contains, in addi-
tion to functional catalytic regions, two SH2 domains (N- and
C-terminal) and an SH3 domain. The SH2 domains of PLC1, in
particular, have been shown to play an important role in regulat-
Figure1. EphA4 activates PLC1.A, Transfection of EphA4 increased the phosphorylation of overexpressed PLC1 on tyrosine
783, a site known to correlate with PLC activity. Expression of a kinase-dead form of EphA4, however, did not elevate PLC1
phosphorylation. Note that transfection of PLC1 alone led to a slight increase in phosphorylation over the control transfected
condition (pcDNA3). Shown are blots of lysates derived from cells transfectedwith the indicated constructs.B, Stimulation (Stim)
of EphA4 transfected COS7 cells for 45 min with ephrin-A3 Fc- or ephrin-A5 Fc-induced phosphorylation of endogenous PLC1.
PLC1was immunoprecipitated after stimulation of cells with control Fc, ephrin-A3 Fc, or ephrin-A5 Fc and probed for phosphor-
ylation on tyrosine 783. Themembranewas subsequently stripped and reprobed for PLC1. Control IgGswere used to confirm the
specificity of the immunoprecipitation. Quantification of these changes showed that both ephrin-A3 Fc and ephrin-A5 Fc signif-
icantly increased PLC1 phosphorylation (*p 0.05, ANOVA). C, Immunoblots of lysates of cells stimulated with control Fc or
ephrin-A Fc. Ephrin-A stimulation caused a significant increase in phosphorylation of Y783, but not Y771or S1248of PLC1 (*p
0.02, t test). D, Immunofluorescence labeling showing increased labeling of EphA4 transfected COS7 cells with the anti-pY783
antibody. Note that the labelingwas seen as clusters on the cell body (arrow) andprocesses (arrowhead) of EphA4, but not control
transfected cells (EGFPf). KD, Kinase-dead. Scale bar, 30m. Error bars indicate SEM.
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ing its function through protein interactions with activated re-
ceptor tyrosine kinases (Rebecchi and Pentyala, 2000). We were
interested in testing whether EphA4 may interact with PLC1
through binding its SH2 domains. Indeed, EphA4 has been re-
ported to recruit SH2 domain containing proteins including Fyn,
Src, and Vav2 through its highly conserved juxtamembrane ty-
rosine residues (Kalo and Pasquale, 1999; Cowan et al., 2005). To
address whether EphA4 binds PLC1 through an SH2-domain
interaction, we performedGST pull-down experiments using the
SH2 domains of PLC1 fused to GST and EphA4-transfected
COS7 cell lysates. We found that the C-terminal SH2 domain of
PLC1 bound strongly to ephrin-A-stimulated EphA4 express-
ing COS7 cells (Fig. 3A). We could not detect binding of the
N-terminal SH2 domain to EphA4. The binding to the
C-terminal SH2 domain, however, was severely diminished after
mutating either of the conserved juxtamembrane tyrosines of
EphA4 to glutamic acid (Y596E or Y602E). Glutamic acid muta-
tions have been shown to eliminate SH2-domain interactions of
Eph receptors without interfering with kinase activity (Zisch et
al., 2000; Cowan et al., 2005). We did observe very weak binding
of the EphA4 Y596E mutant to the C-terminal SH2 domain of
PLC1 after long film exposures (data not shown), but no bind-
ing to the Y602Emutant. Phosphorylation of these tyrosinesmay
function cooperatively to recruit PLC1.
We further extended these findings by investigating the re-
quirement of the EphA4 juxtamembrane tyrosines for PLC1
activation after ephrin stimulation. We found that both the
Y596E and Y602E mutants were compromised in their ability to
activate PLC1 above control Fc treatment levels in the presence
of ephrin stimulation (Fig. 3B). However, the Y596E mutant ap-
peared to have higher basal ability to cause PLC1 phosphoryla-
tion in the absence of ephrin, suggesting that this mutation may
mimic phosphorylation on EphA4 and lead to a partial activation
of PLC1 in the absence of ligand. The Y602E mutant, in con-
trast, only weakly phosphorylated PLC1 in the presence of eph-
rin, indicating that phosphorylation of tyrosine 602 of EphA4 is
important for activating PLC1. Altogether, these results suggest
that EphA4 uses juxtamembrane tyrosines to interact with the
C-terminal SH2 domain of PLC1.
We also further tested the interaction between EphA4 and
PLC1 by coimmunoprecipitation experiments, in vitro kinase
assays, and double-label immunofluorescence in hippocampal
slices. We found that EphA4 coimmunoprecipitated with PLC1
from lysates derived fromCOS7 cells (data not shown) and adult
mouse hippocampus (Fig. 3C). The EphA4 kinase domain was
also able to phosphorylate Y783 of PLC1 (Fig. 3D) in in vitro
kinase assays. Furthermore, we found that EphA4 and PLC1
colocalized on at least a subset of spines (supplemental Fig. 2,
available at www.jneurosci.org as supplemental material). How-
ever, we could not rule out the possibility that we did not detect
the full extent of these proteins because immunofluorescence is
not a sensitive method to detect the subcellular location of pro-
teins in tissues. Thus, these proteins may be more prevalent than
what is observed in supplemental Figure 2 (available at www.
jneurosci.org as supplemental material). Synaptosome fraction-
ation, amore sensitive technique, was performed to further char-
acterize the postsynaptic localization of PLC1.
PLC1 is localized in several compartments of brain
synaptosomes and cofractionates with postsynaptic density
proteins
Several reports have implicated PLC1 in synaptic transmission
and plasticity (Reyes-Harde and Stanton, 1998; Micheva et al.,
2001; Gartner et al., 2006). It also has been shown that PLC1 is
detected in the adult brain and hippocampus (CA1–3 regions)
through in situ hybridization and immunohistochemistry (Ger-
fen et al., 1988; Ross et al., 1989). One report suggested that PLC
Figure2. Ephrin stimulation induces the activation of PLC1 in hippocampal slices.A, Stim-
ulation (Stim) of hippocampal slices with ephrin-A Fc induced phosphorylation of endogenous
EphA4 and PLC1. After 45 min of ephrin-A Fc or control Fc stimulation of slices, EphA4 or
PLC1 were immunoprecipitated and blotted for phosphotyrosine (pY20) or pY783 of PLC1,
respectively. Control IgGswereused to confirmthe specificity of the immunoprecipitation (IP).Mem-
branes were subsequently stripped and reprobed for either EphA4 or PLC1 to ensure that equal
amounts of protein were initially immunoprecipitated. B, C, Time-course analysis showing PLC1
phosphorylation after 45 min of stimulation. Quantification of these changes showed a significant
increase in phosphorylation at 45min (**p 0.01, ANOVA). Error bars indicate SEM.
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isoforms function postsynaptically to
block long-term synaptic plasticity (Reyes-
Harde and Stanton, 1998). This was ob-
served after infusion of the PLC inhibitor
U73122 into CA1 pyramidal cells, which
blocked the induction of hippocampal
long-term depression (LTD). However, it
remains unclear whether PLC1 is posi-
tioned to influence the postsynaptic termi-
nal, including dendritic spines. To pursue
this issue, we purified brain synaptosomes
and further separated them into presynap-
tic and postsynaptic elements (Phillips et
al., 2001). We found that PLC1 is found
inmultiple synaptic compartments, show-
ing cofractionation with presynaptic ac-
tive zones and extrajunctional regions.
However, similar to PSD-95, PLC1 was
readily apparent in postsynaptic density
fractions, including the Triton-insoluble
“core” PSD fraction (PSD III) (supple-
mental methods, available at www.
jneurosci.org as supplemental material)
(Fig. 4). These results indicate that PLC1
is localized to various regions of the syn-
apse, including postsynaptic terminals,
and could play a role in regulating
postsynaptic properties including den-
dritic spine structure.
PLC signaling maintains dendritic
spine morphology
Because PLC1 is found in postsynaptic
fractions of synaptosomes and is known to
be involved in synaptic function, we were
interested in testing whether PLC1 activ-
ity may influence postsynaptic dendritic
spine morphology. To test this possibility,
we used Semliki Forest viruses to intro-
duce wild-type PLC1 or a lipase-inactive
mutant of PLC1 (PLC1 LIM) into CA1
pyramidal cells of organotypic hippocam-
pal slices (Fig. 5A). The latter of which has
been shown to function as a dominant-
negative protein (Huang et al., 1995;
Ronnstrand et al., 1999; Rong et al., 2003).
We analyzed the morphology of CA1 py-
ramidal cell spines after 20 h of expression.
No apparent changes in overall dendrite
length or branching, or signs of dendritic
pathologywere observed in any of the con-
ditions. Overexpression of wild-type
PLC1 did not significantly affect the
structural properties of dendritic spines
when compared with EGFPf controls. In-
terestingly, the PLC1 LIM induced pro-
found changes in spine morphology. In
particular, spines showed a significant increase in length and area
whereas the number of spines per unit length was reduced (Fig.
5). In some cases, the spines showed an abnormal phenotype,
having multiple head portions with a very complex architecture.
However, most spines in this condition retained a bulbous ap-
pearance with an enlarged head portion attached to the dendritic
shaft through a narrow neck region. This was further corrobo-
rated by classifying spines into mushroom, stubby, elongated, or
other-type morphologies. We found that expression of the
PLC1 LIM caused a significant loss of stubby spines. Although
expression of wild-type PLC1 did slightly reduce the amount of
stubby spines, this effect was not significant when compared with
Figure 3. EphA4 interacts with PLC1. A, GST pull-down assay using the N- (N-SH2) and C-terminal SH2 domains (C-SH2) of
PLC1 and lysates from COS7 cells transfected with wild-type EphA4, Y596E EphA4 mutant, or Y602E EphA4 mutant and stimu-
lated with ephrin-A Fc. EphA4 strongly bound the C-terminal SH2 domain of PLC1. We observed very weak binding of the
C-terminal SH2 domain to the Y596Emutant after long film exposures. Lysates to the right (representing only 0.4%of total input)
confirm the expression of the transfected receptors in each of the conditions used for the pull-down experiments. B, Stimulation
of transfected (trans) COS7 cells expressing wild-type, Y596E, or Y602E mutants of EphA4 with ephrin-A Fc showed that both
Y596E and Y602E EphA4 mutants have compromised ability to activate PLC1 after ephrin-A stimulation (Stim). PLC1 was
immunoprecipitated after stimulation of cells with control Fc or ephrin-A Fc and probed for phosphorylation on tyrosine 783. The
membrane was subsequently stripped and reprobed for PLC1. The Y596E mutant appeared to have higher basal ability to
activate PLC1. The Y602E mutant showed only low levels of PLC1 activation after ephrin-A stimulation. C, EphA4 coimmuno-
precipitatedwith PLC1 from postnatal day 21mouse hippocampus. PLC1 or control IgG immunoprecipitates (IP) were blotted
for EphA4. D, PLC1 immunoprecipitates were subjected to in vitro kinase assays with or without a recombinant EphA4 kinase
domain. The EphA4kinasedomainphosphorylatedPLC1on tyrosine783. Theblotswere subsequently strippedand reprobed for
PLC1 protein (*p 0.05, t test). Error bars indicate SEM.
Figure 4. PLC1 is found in multiple compartments of synaptosomes, but is enriched in postsynaptic density fractions. A,
PLC1was found in nonsynaptic fractions (cytosolic andmicrosomal) and in synapticmembranes and vesicles in the adultmouse
brain as shown by immunoblotting with the anti-PLC1 polyclonal antisera. Antibodies against NR1 and synaptophysin were
used as synapticmembrane and synaptic vesiclemarkers, respectively.B, PLC1was present on both sides of the synapse. PLC1
was detected in presynaptic active zones and extrajunctional membrane fractions and was readily apparent in the PSD fraction.
SNAP25 and PSD95were used as presynaptic and postsynaptic densitymarkers, respectively. C, PLC1 is strongly associatedwith
PSDs. PLC1was insoluble to 1%TritonX-100 (PSD I and II) and3%sarcosyl (PSD III) and remained associatedwith the “core” PSD
(PSD III) (supplemental methods, available at www.jneurosci.org as supplemental material).
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the control. These results suggest that PLC1 signaling is re-
quired for spine stability and maintaining dendritic spine archi-
tecture, especially those with a stubby, retracted appearance.
In a separate set of experiments, we also tested the require-
ment of PLC1 in maintaining dendritic spine morphology. To
investigate this, we performed RNA interference (RNAi) by bi-
olistically delivering a plasmid to CA1 pyramidal cells that simul-
taneously induces the expression of a short-hairpin RNAdirected
against PLC1 (supplemental Fig. 1, available at www.
jneurosci.org as supplemental material) and drives the expres-
sion of EGFPf. The sequence used for RNAi has been character-
ized previously and shown to selectively knock down PLC1 ex-
pression, although leaving the expression of the closely related
family member PLC2 intact (Patterson et al., 2002). A plasmid
that drives the expression a scrambled sequence of the PLC1
shRNA was used as a control. Consistent with the experiments
above using the PLC1 LIM, knockdown of PLC1 expression
significantly reduced the density of dendritic spines.However, we
could not detect significant changes in
overall spine morphology or classification
(data not shown). A potential explanation
for this may be that the RNAi experiments
were performed after 72 h of knockdown
in CA1 cells (vs 20 h for the PLC1 LIM
experiments). It is possible that spines
with perturbed morphology collapsed
during the 72 h period of PLC1 knock-
down which, in turn, caused the reduction
in spine density.
We attempted to rescue the spine phe-
notype using a mutated form of PLC1
(with the RNAi site mutated in four wob-
ble positions), but this was not successful
(data not shown). However, many techni-
cal issues could have complicated the res-
cue. One reason may be the timing of ex-
pression of the PLC1 shRNA and the
rescue protein, which use different pro-
moters (H1 RNA pol III and cytomegalo-
virus, respectively) and different cellular
mechanisms for their production. Based
on our experiments with PLC1 RNAi in
NIH3T3 cells (which found that 72 h was
needed for efficient PLC1 knockdown),
we assessed spine morphology and density
in CA1 neurons in hippocampal slices
after 72 h of expression. However, it was
unclear whether the lack of rescue was at-
tributable to insufficient levels of the
rescue protein present during PLC1
knockdown.
PLC signaling is necessary for ephrin-
induced spine shrinkage
We next wanted to determine whether
PLC1 signaling was required for trans-
mitting signals downstream of EphA4 in
dendritic spines. Previously, we showed
that EphA4 is localized on dendritic spines
and 45 min of ephrin treatment of hip-
pocampal slices induced spine retraction
in a kinase-dependent manner (Murai et
al., 2003a).We further showed that EphA4
is the main EphA class receptor mediating these effects. Further-
more, stimulation of EphB receptors only induced small changes
in dendritic spines in area CA1 of the hippocampus. To address
whether PLC signalingwas required for the acute effects of ephrin
treatment on dendritic spine morphology, we incubated hip-
pocampal slices with either ephrin-A or control Fc proteins in the
presence of either the PLC inhibitor U73122 (see Materials and
Methods) or control analog U73343 (Fig. 6). We found that in-
cubation of slices with control Fc proteins along with the PLC
inhibitor did not significantly affect the individual parameters of
dendritic spines. The PLC inhibitor, however, caused a signifi-
cant reduction in mushroom-type spines when compared with
the control condition (Fc with control analog) (Fig. 6E), while
not affecting the percentage of stubby, elongated, or other-type
spines. This result differs fromwhat we observed previously after
longer-term expression of the PLC1 LIM andmay reflect differ-
ential effects on spines under acute (PLC inhibitor) or prolonged
(PLC1 LIM) blockade of PLC signaling. Similar to what was
Figure 5. PLC1 activity is necessary for maintaining CA1 dendritic spine morphology. A, Examples showing abnormal den-
dritic spinemorphology after expression of the PLC1 LIMwhen comparedwith control CA1 cells expressingmembrane-targeted
EGFPf. B, Quantification of spine parameters showed that spine density was significantly reduced after expression of the PLC1
LIM when compared with control. Significant increases in area and length of spines were also found. Spine width, although on
average larger in the PLC1 LIM condition, was not significantly different among groups. No prominent changes were observed
after overexpressingwild-type PLC1 (*p 0.05, **p 0.01, ANOVAwith Student–Newman–Keuls post hoc comparisons). C,
Expression of the PLC1 LIM also induced a significant decrease in the number of stubby-type spines (*p 0.05, **p 0.01
ANOVA with Student–Newman–Keuls post hoc comparisons). D, RNAi in organotypic slices after biolistic delivery of a vector
expressing a PLC1 shRNA showed that PLC1 is necessary formaintaining spine density (*p 0.05, t test). Scale bars:A, 5m;
high-magnification images of individual spines, 1m. Error bars indicate SEM.
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reported previously (Murai et al., 2003a),
acute ephrin-A treatment induced spine
retraction (Kolmogorov–Smirnoff two-
sample test, p  0.05) and significantly
promoted the generation of stubby spines
(Fig. 6E). The generation of these spines
was likely at the expense of mushroom-
type spines because overall spine density
was not significantly perturbed in any of
the treatments. Remarkably, simultaneous
treatment of slices withU73122 alongwith
ephrin blocked the effects of ephrin on in-
ducing the stubby dendritic spine pheno-
type (Fig. 6D,E). The percentage of both
mushroom and stubby type spines was
similar between conditions composed of
the U73122 with either Fc or ephrin-A.
These results suggest that PLC signaling is
necessary for the effects of ephrin-A-
induced generation of stubby and re-
tracted dendritic spines. It should be noted
thatU73122, although specific for PLC en-
zymes, can inhibit multiple PLC isoforms
(Smith et al., 1990). However, the only
other PLC isoform that is known to signal
downstream of RTKs other than PLC1 is
PLC2, whose expression is restricted to
the anterior lobe of the pituitary and the
cerebellum (Tanaka and Kondo, 1994).
However, we cannot rule out the possibil-
ity that Eph receptors can signal through
other PLC proteins (i.e., PLC forms that
are not commonly associated with RTKs)
and that this signaling would be blocked
by U73122.
PLC signaling regulates the localization
of the actin-depolymerizing and -
severing factor cofilin
Previous studies have proposed that
PLC1, by generating IP3 andDAGsecond
messengers from cleavage of PIP2, plays an
important role in regulating cell mem-
brane levels of PIP2. PIP2 itself can have
dramatic effects on cell behavior and
cytoskeletal-plasma membrane adhesion
(Raucher et al., 2000). PIP2 may act as a
secondmessenger by binding andmodify-
ing the activity state of various proteins in-
cluding ion channels and actin-binding
proteins such as cofilin, a protein previously implicated in the
structural plasticity of spines (Zhou et al., 2004). Cleavage of PIP2
by PLC1may thus serve tomodulate PIP2–protein interactions.
It has been shown that PIP2 tethers gelsolin to the cell surface and
releases it after EGF stimulation and PLC signaling (Chou et al.,
2002). We were interested in investigating the possibility that
EphA4 and PLC1 signaling regulates cofilin association with the
cell membrane because cofilin is highly expressed in dendritic
spines, binds PIP2, and has been implicated in mediating the
effects of dendritic spine shrinkage after low-frequency, LTD-
inducing stimuli (Zhou et al., 2004; Racz and Weinberg, 2006).
To test this, we performed cellular fractionation experiments in
which we isolated membrane components of COS7 cells after
U73122 or control analog treatment. We found that blocking
PLC activity with U73122 significantly enhanced the level of co-
filin that was associated with the cell membrane (Fig. 7A). This is
in contrast to the transferrin receptor, a nonraft localized recep-
tor associated with the cell membrane, whose membrane associ-
ation was not altered by U73122 treatment. These results are in
accordance with other reports that indicate that a portion of co-
filin is associated with the cell periphery (Suzuki et al., 1995;
Heyworth et al., 1997). Interestingly, we also found that transfec-
tion of EphA4 alone could reduce the levels of cofilin found in the
membrane fraction. We could also further decrease this amount
with ephrin-A stimulation (Fig. 7B). Similarly, ephrin stimula-
tion of hippocampal slices derived from postnatal day 10 mouse
Figure 6. PLC activity is necessary for ephrin-A-induced dendritic spine retraction. A–D, DiI-labeled CA1 dendritic spines in
hippocampal slices stimulatedwith Fc and control analog (A), Fc and PLC inhibitor (B), ephrin Fc and control analog (C), or ephrin
Fc and PLC inhibitor (D). Note the retracted appearance of dendritic spines in C. Classification of spines showed that application of
the PLC inhibitor blocked the ability of ephrin to induce a retracted, stubby spine phenotype. Treatment of slices with Fc or ephrin
Fc with the PLC inhibitor significantly decreased the percentage of mushroom-shaped spines, suggesting that blocking PLC
activity alone can destabilize mushroom-type spines (*p 0.05, **p 0.01 ANOVA with Student–Newman–Keuls post hoc
comparisons). Scale bar: A, 5m; high-magnification, 0.5m. Error bars indicate SEM.
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brain also significantly caused a reduction in the level of cofilin
associated with the cell membrane (Fig. 7C). However, because
we are using hippocampal tissue, the effects that we observedmay
be complicated by cofilin located in other cell types in addition to
neurons that are found in slices such as oligdendrocytes and
astrocytes.
These collective results suggest that EphA4 signaling and PLC
activation contribute to the release of a pool of cofilin associated
with the cell membrane. Removal of the membrane tethering of
cofilin may release it from inhibition and allow it to bind and
depolymerize actin filaments (DesMarais et al., 2005).
Discussion
The structural properties of dendritic spines are believed to be
closely linked to the physiology of excitatory synapses (Segal,
2005). Spine anatomy is also disrupted in several diseases affect-
ing the brain including Down, Fragile-X, and Williams syn-
dromes, suggesting altered synapsemorphology is related to cog-
nitive impairments (Sawa and Snyder, 2002). Previous studies
have elucidated the molecular composition of spines and mech-
anisms that govern their morphology (Tada and Sheng, 2006).
However, few reports have revealed the signaling cascades that
couple receptors to direct regulators of the actin-rich cytoskele-
ton in spines. Here, we report a novel signaling pathway down-
stream of the EphA4 receptor tyrosine kinase linking PLC1 to
the actin- depolymerizing/severing protein cofilin. We found
that ephrin stimulation promotes the interaction between the
juxtamembrane tyrosines of EphA4 and the C-terminal SH2 do-
main of PLC1. PLC1 signaling is critical for maintaining spine
morphology and PLC activity is required for ephrin-induced
spine retraction. Remarkably, the amount of cofilin associated
with the cell membrane is regulated by PLC and EphA4 activity.
This signaling may be important for the local remodeling of the
actin cytoskeleton in spines at sites of ephrin-A/EphA4 contact.
Spines rely on actin filaments for their dynamics and these
filaments are in a constant state of equilibrium, cycling between
filamentous actin (F-actin) and globular actin (G-actin) forms.
Time-lapse imaging has shown that actin is rapidly reorganized
in spines over minutes (Fischer et al., 1998). Long-term potenti-
ation (LTP)-inducing stimuli increases F-actin in spines that oc-
curs during spine enlargement (Okamoto et al., 2004). Low-
frequency stimulation, in contrast, increases G-actin levels and
causes spine shrinkage. Furthermore, pharmacological inhibi-
tion of actin polymerization blocks the induction and mainte-
nance of LTP in hippocampal slices (Kim and Lisman, 1999).
Thus, actin filament dynamics are related to bidirectional
changes in the structural and physiological plasticity of excitatory
synapses.
Previous studies indicate a critical role for Eph receptors in
spine morphogenesis and maintenance (Murai and Pasquale,
2004). EphB2 induces spine development in hippocampal neu-
rons by phosphorylating the proteoglycan syndecan-2 (Ethell et
al., 2001) and assembling a complex that elicits RhoA signaling
(Moeller et al., 2006). Other studies have shown that EphB2 ac-
tivates the exchange factors intersectin and kalirin to promote
spine development throughCdc42 andRac, respectively (Irie and
Yamaguchi, 2002; Penzes et al., 2003). There is some redundancy
for EphB receptors because only neurons from double and triple
knock-outs of EphB1, EphB2, and EphB3 exhibit changes in
spine density and morphology (Henkemeyer et al., 2003;
Hoogenraad et al., 2005). Interestingly, F-actin is accumulated in
dendritic shafts rather than spines of EphB knock-out mice, sug-
gesting that EphB receptors influence the distribution of actin
filaments (Henkemeyer et al., 2003). To date, the only EphA re-
ceptor shown tomodulate spine morphology is EphA4 (Murai et
al., 2003a). EphA4 is enriched in the developing and adult mouse
hippocampus and is localized on spines (Murai et al., 2003a,b).
Activation of EphA4 by ephrin-A results in spine retraction (Mu-
rai et al., 2003a). This could be mediated by EphA4 signaling
induced by contact with ephrins on neurons or glia. Interestingly,
during the review of this paper, a study showed that EphA4 me-
diates spine development through the Rho-family GTPase ex-
change factor, ephexin-1, and the serine/threonine kinase Cdk5
(Fu et al., 2007). In vivo, EphA4 knock-out mice have disorga-
nized and abnormally shaped spines (Murai et al., 2003a), and
decreases in early-phase LTP and in LTD (Grunwald et al., 2004).
However, mice with the cytoplasmic portion of EphA4 replaced
by GFP appear to have normal LTP and LTD under standard
induction paradigms. Thus, EphA4 may have kinase-dependent
and independent functions that control the structural and phys-
iological plasticity of excitatory synapses. These collective studies
demonstrate that Eph receptors are important determinants of
spine shape in vitro and in vivo.
Our findings suggest that EphA4 regulates spine morphology
Figure 7. PLC activity and ephrin stimulation alter the membrane association of the actin-
depolymerizing/severing protein cofilin. A, Application of the PLC inhibitor (3 h) increased the
levels of cofilin associated with the cell membrane of COS7 cells. The transferrin receptor (TfR)
was used to ensure equal loading among lanes. B, EphA4 expression in COS7 cells reduces the
membrane-association of cofilin. This association was further reduced by ephrin stimulation
(*p 0.05, ANOVAwith Student–Newman–Keuls post hoc comparisons; **p 0.01, t test or
ANOVAwith Student–Newman–Keuls post hoc comparisons). C, Ephrin treatment of postnatal
day 10 hippocampal slices also reduced the level of cofilin associated with the cell membrane
(*p 0.05, t test). Error bars indicate SEM.
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through a pathway different from what has been described pre-
viously for Eph receptors.Many of the events downstreamof Eph
receptors require activation of small GTPases that remodel the
spine’s actin cytoskeleton. Eph receptors also interact with the
PDZ (PSD-95/Discs large/zona occludens-1)-domain proteins
GRIP (glutamate receptor-interacting protein) andAF6 (Hock et
al., 1998; Torres et al., 1998). These interactions, however,may be
more pertinent to receptor trafficking (Hoogenraad et al., 2005).
Our results suggest that EphA4 likely uses tyrosine 602 in the
juxtamembrane region to activate PLC1 through its C-terminal
SH2 domain. Coimmunoprecipitation experiments further indi-
cate that EphA4 and PLC1 can interact directly or within the
same molecular complex in the hippocampus. EphA4 is known
to recruit and bind several proteins including Src, Fyn, and Vav2
through SH2-domain interactions (Ellis et al., 1996; Zisch et al.,
1998; Cowan et al., 2005). The significance of these interactions at
synapses has not been reported. Interestingly, cortical neurons
derived from Fyn-null mice show reduced spine density (Kalo
and Pasquale, 1999; Morita et al., 2006). Thus, Fyn and PLC1
may similarly bind to the juxtamembrane tyrosines of EphA4 to
modify synaptic structure. However, the delayed kinetics of
PLC1 activation after ephrin treatment and the fact that EphA4
and PLC1 only partially colocalize in a subset of spines leaves
open the possibility that an intermediary protein downstream of
EphA4 induces the activation of PLC1. Additional experiments
are necessary to fully develop the direct or indirect nature of the
EphA4-PLC1 interaction.
After activation by RTKs, phosphorylated PLC1 plays di-
verse roles in cellular behavior (Rebecchi and Pentyala, 2000).
Previous data suggests that PLC1 controls the level of
membrane-bound PIP2, which by itself acts as a potent second
messenger that modifies actin–plasma membrane interactions
and cell adhesion (Raucher et al., 2000; DesMarais et al., 2005).
PIP2 also modulates the function of many proteins including
potassium and TRP (transient receptor potential) channels
(Lopes et al., 2005; Rohacs et al., 2005) and actin-binding pro-
teins (Sechi and Wehland, 2000). Furthermore, PIP2 actively
competes with actin for binding cofilin and inhibits its actin de-
polymerizing ability in vitro (Yonezawa et al., 1990, 1991b). Re-
ciprocally, cofilin binding to PIP2 blocks PLC1-mediated cleav-
age of PIP2 (Yonezawa et al., 1991a). PLC-PIP2 interactions are
known to be important for the dynamic regulation of the actin
cytoskeleton and for cell motility after EGF stimulation (Chou et
al., 2002). Ephrin/EphA4 signaling may provide a trigger for
PLC1-dependent regulation of cofilin at the cell surface in dy-
namic compartments of neurons such as spines and growth
cones. At the same time, generation of the secondmessengers IP3
and DAG by PIP2 hydrolysis may influence synaptic function
(Lynch et al., 1988; Nagase et al., 2003; Taufiq et al., 2005). Ad-
ditional experiments are needed to determine whether EphA4-
PLC1 interactionsmodify spinemorphology and synaptic func-
tion through these second messenger systems.
Cofilin may exist in different transient states that are impor-
tant for spine morphology. Reports have suggested that cofilin
association near the cell membrane is enhanced when it is in the
dephosphorylated, activated state (Mulholland et al., 1994; Su-
zuki et al., 1995; Nagaoka et al., 1996). Phosphorylation of cofi-
lin/ADFproteins on serine-3 also blocks their ability to bind actin
(Morgan et al., 1993; Moriyama et al., 1996). Thus, PIP2 may
tether cofilin to the cell surface and maintain it in a “primed”
(dephosphorylated but inactive) state awaiting RTK autophos-
phorylation. After PLC1 activation by EphA4, cofilin may be
released to depolymerize and sever actin filaments in the spine
(Matus, 2000). Cofilin may need to be released from PIP2 inhibi-
tion and from the outer membrane perimeter of the spine to play
a role in the “core” of the spine to alter its structure (Racz and
Weinberg, 2006).
After release, LIM and Tes kinases may decrease cofilin activ-
ity through phosphorylation on serine-3. Indeed, LIM kinase 1
(LK1) knock-out mice have reductions in cofilin phosphoryla-
tion and spine size (Meng et al., 2002). This is consistent with
cofilin promoting actin filament disassembly and spine shrinkage
(Zhou et al., 2004). Physiological recordings and behavioral anal-
ysis of LK1 knock-outmice have shown that basal synaptic trans-
mission is normal, however, the mice have elevated LTP and
impairments on memory tasks (Meng et al., 2002). Additionally,
a microRNA that reduces the translation of LK1 is modulated by
BDNF and blocks spine development (Schratt et al., 2006). Cofi-
lin is reactivated by Slingshot proteins through dephosphoryla-
tion of serine-3 (Niwa et al., 2002) and the mRNAs for these
proteins are found in the developing and adult mouse brain
(Ohta et al., 2003). The role of Slingshot proteins in regulating
spine morphology, however, remains unknown. Remarkably, a
previous study suggests that cofilin phosphorylation/dephos-
phorylation events are not necessarily required for cofilin activity
in dynamic leading edges of carcinoma cells in response to EGF
treatment (Song et al., 2006). In this context, translocation of
cofilin is likely critical for its function in cellular remodeling. This
supports the hypothesis that cofilin exists in different states and is
regulated atmultiple levels to control its localization and activity.
In summary, our results provide new insight into how EphA
receptors control spine morphology. The combinatorial control
overmultiple downstream targets of activated EphA and B recep-
tors, including signaling through PLC1, ephexin-1, Rho-family
GTPases, and cofilin, is likely required for proper spine develop-
ment and maintenance.
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